期刊文献+

全反式维A酸对恶性黑素瘤A375细胞上皮-间质转化相关分子表达的影响 被引量:1

Effect of all-trans retinoic acid on the expression of epithelial-mesenchymal transition-related molecules in human malignant melanoma A375 cells
原文传递
导出
摘要 目的研究全反式维A酸(ATRA)对人恶性黑素瘤A375细胞中上皮-间质转化(EMT)相关分子表达的影响。方法用含10μmol/L ATRA的DMEM培养基和DMEM培养基分别处理A375细胞24和48 h作为ATRA-1组和ATRA-2组、对照1组和对照2组,采用实时定量PCR法检测EMT相关基因上皮钙黏着蛋白、神经钙黏着蛋白、波形蛋白、β联蛋白mRNA的表达。Western印迹法检测ATRA-1组、ATRA-2组、对照1组中上述蛋白的相对表达量,直接免疫荧光法检测上皮钙黏着蛋白和波形蛋白的荧光强度。统计分析采用两因素方差分析、单因素方差分析及LSD-t检验。结果ATRA-1组和ATRA-2组分别与对照1组和对照2组相比,上皮钙黏着蛋白mRNA的表达均显著增加(F=13.148、31.529,P<0.05),而神经钙黏着蛋白、波形蛋白、β联蛋白mRNA的表达均显著降低(均P<0.05);ATRA-2组上皮钙黏着蛋白mRNA的表达显著高于ATRA-1组(F=13.148,P<0.05),而其他3种蛋白mRNA的表达显著低于ATRA-1组(均P<0.05);对照1组与对照2组上述蛋白的mRNA表达差异无统计学意义(均P>0.05)。Western印迹法显示,与对照1组相比,ATRA-1组和ATRA-2组上皮钙黏着蛋白表达上调,而神经钙黏着蛋白、波形蛋白、β联蛋白表达均下调(均P<0.05);与ATRA-1组相比,ATRA-2组上皮钙黏着蛋白表达上调(P<0.05),神经钙黏着蛋白、波形蛋白、β联蛋白表达下调(均P<0.05)。直接免疫荧光显示,ATRA-1组、ATRA-2组上皮钙黏着蛋白的荧光强度(6.23±0.08、10.37±0.13)显著高于对照1组(2.37±0.14,均P<0.05),而波形蛋白的荧光强度(15.17±0.18、10.29±0.03)显著低于对照1组(50.16±0.26,均P<0.05),抑制上皮向间质转化。结论ATRA可上调A375细胞中上皮钙黏着蛋白的表达,降低神经钙黏着蛋白、波形蛋白、β联蛋白的表达,可能抑制A375细胞发生EMT现象。 Objective To evaluate the effect of all-trans retinoic acid(ATRA)on the expression of epithelial-mesenchymal transition(EMT)-related molecules in human malignant melanoma A375 cells.Methods Cultured A375 cells were divided into 4 groups:control-1 and-2 groups treated with Dulbecco′s modified Eagle medium(DMEM)for 24 and 48 hours respectively,and ATRA-1 and ATRA-2 groups treated with DMEM containing 10μmol/L ATRA for 24 and 48 hours respectively.After the treatment,real-time quantitative PCR was performed to determine the mRNA expression of EMT-related genes E-cadherin,N-cadherin,vimentin andβ-catenin in the above 4 groups,Western blot analysis to determine the relative expression of the above proteins,and direct immunofluorescence study to assess the fluorescence intensity of E-cadherin and vimentin in the ATRA-1,ATRA-2 and control-1 groups.Statistical analysis was carried out by using two-way analysis of variance,one-way analysis of variance and least significant difference-t test.Results Real-time quantitative PCR showed that the E-cadherin mRNA expression was significantly higher in the ATRA-1 group than in the control-1 group(F=13.148,P<0.05),and higher in the ATRA-2 group than in the control-2 group(F=31.529,P<0.05);the mRNA expression of N-cadherin,vimentin andβ-catenin was significantly lower in the ATRA-1 group than in the control-1 group(P<0.05),and lower in the ATRA-2 group than in the control-2 group(P<0.05);the ATRA-2 group showed significantly increased mRNA expression of E-cadherin(F=13.148,P<0.05),but significantly decreased mRNA expression of the other 3 proteins compared with the ATRA-1 group(all P<0.05);there was no significant difference in the mRNA expression of the above molecules between the control-1 and-2 groups(all P>0.05).Western blot analysis showed that the protein expression of E-cadherin significantly increased,but the protein expression of N-cadherin,vimentin andβ-catenin significantly decreased in the ATRA-1 and ATRA-2 groups compared with the control-1 group(all P<0.05);compared with the ATRA-1 group,the ATRA-2 group showed significantly increased protein expression of E-cadherin(P<0.05),but significantly decreased protein expression of N-cadherin,vimentin andβ-catenin(all P<0.05).Direct immunofluorescence study showed that the fluorescence intensity of E-cadherin was significantly higher in the ATRA-1 group and ATRA-2 group(6.23±0.08,10.37±0.13,respectively)than in the control-1 group(2.37±0.14,both P<0.05),while the fluorescence intensity of vimentin was significantly lower in the ATRA-1 group and ATRA-2 group(15.17±0.18,10.29±0.03,respectively)than in the control-1 group(50.16±0.26,both P<0.05),and the cells in the ATRA-1 group and ATRA-2 group transformed from spindle-to cobble-stone-like in shape.Conclusion ATRA can up-regulate the expression of E-cadherin,down-regulate the expression of N-cadherin,vimentin andβ-catenin in A375 cells,and may inhibit the EMT of A375 cells.
作者 向桂琼 樊卓 党云 郭坤 耿松梅 Xiang Guiqiong;Fan Zhuo;Dang Yun;Guo Kun;Geng Songmei(Department of Dermatology,The First Affiliated Hospital of Xi′an Medical University,Xi′an 710077,China;Department of Dermatology,The Second Affiliated Hospital of Xi′an Jiaotong University,Xi′an 710004,China)
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2021年第1期50-55,共6页 Chinese Journal of Dermatology
基金 国家自然科学基金(81372912、51707149) 西安交通大学基本科研业务费(xjj2017071)。
关键词 黑色素瘤 上皮-间质转化 钙黏着糖蛋白类 波形蛋白 Β连环素 全反式维A酸 Melanoma Epithelial-mesenchymal transition Cadherins Vimentin beta Catenin All-trans retinoic acid
  • 相关文献

参考文献4

二级参考文献40

  • 1邵世宏,姚运红.干细胞、肿瘤干细胞与肿瘤的关系[J].现代肿瘤医学,2005,13(3):430-432. 被引量:13
  • 2Prince ME, Sivanandan R, Kaezorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous ceil carcinoma [ J ]. Biological Sciences/Medical Sciences, 2007, 104 (3) : 973 -978.
  • 3Liu J, Song L, Zhang X, et al. BMI-1 Expression Predicts Prognosis for Patients With Gastric Carcinoma[ J]. Journal of Surgical Oncology, 2008, 97 (3) : 267 - 272.
  • 4Kim JH, Yoon SY, KJm CN, et al. The BMI-1 oncoprotein is over-expressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins[J]. Cancer Lett, 2004, 203 (2) : 217 -224.
  • 5Bruggeman A, Sophia WM, Valk-lingbeek L, et al. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in BMI-1-deficient mice [ J ]. Genes Devel, 2005, 19 (12) : 1438 - 1443.
  • 6Mihic-probst D , Kiuster A, Kilgus S, et al. Early Detection and Diagnosism :Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma[J]. International Journal of Cancer, 2007, 121 ( 8): 1764-1770.
  • 7Lotan R. Suppression of squamous cell carcinoma growth and differentiation by retinoids[ J]. Cancer Res, 1994,54 (7) : 1987 -1990.
  • 8Vivat Hannah V,Zusi FC.Retinoids as therapeutic agents:today and tomorrow.Mini Rev Med Chemo,2005;5(8):755-760.
  • 9Niles RM.Recent advances in the use of vitamion A(Retinoids) in the prevention and treatment of cancer.N Μtrition,2000;16(11):1084-1089.
  • 10Tsao H,Atkins MB,Sober AJ.Management of cutaneous melanoma.N Engl J Med,2004;351(10):998-1012.

共引文献3

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部